Terms: = Ovarian cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Treatment
25 results:
1. Proteomics Analysis Revealed smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in ovarian cancer.
Du R; Sun F; Li K; Qi J; Zhong W; Wang W; Sun Q; Deng Q; Wang H; Nie J; Ding C; Hong B
Anticancer Agents Med Chem; 2023; 23(15):1754-1764. PubMed ID: 37194931
[TBL] [Abstract] [Full Text] [Related]
2. FOXO1 mitigates the smad3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract] [Full Text] [Related]
3. Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
Lutgendorf SK; Penedo F; Goodheart MJ; Dahmoush L; Arevalo JMG; Thaker PH; Slavich GM; Sood AK; Cole SW
Cancer; 2020 Oct; 126(19):4407-4413. PubMed ID: 32691853
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/smad3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract] [Full Text] [Related]
5. Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-β pathway.
Wen H; Qian M; He J; Li M; Yu Q; Leng Z
PLoS One; 2020; 15(3):e0230230. PubMed ID: 32214328
[TBL] [Abstract] [Full Text] [Related]
6. Increased androgen receptor levels and signaling in ovarian cancer cells by VEPH1 associated with suppression of smad3 and AKT activation.
Kollara A; Shathasivam P; Park S; Ringuette MJ; Brown TJ
J Steroid Biochem Mol Biol; 2020 Feb; 196():105498. PubMed ID: 31614206
[TBL] [Abstract] [Full Text] [Related]
7. Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression.
Yi Y; Cheng JC; Klausen C; Leung PCK
Exp Cell Res; 2019 Sep; 382(2):111471. PubMed ID: 31229504
[TBL] [Abstract] [Full Text] [Related]
8. smad3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
Shi Y; Zhang J; Liu M; Huang Y; Yin L
J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/smad3 signaling.
Wang Y; Xiang J; Wang J; Ji Y
Biol Res; 2018 Dec; 51(1):58. PubMed ID: 30594239
[TBL] [Abstract] [Full Text] [Related]
10. Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.
Sakr S; Abdulfatah E; Thomas S; Al-Wahab Z; Beydoun R; Morris R; Ali-Fehmi R; Bandyopadhyay S
Int J Gynecol Pathol; 2017 May; 36(3):240-252. PubMed ID: 28727617
[TBL] [Abstract] [Full Text] [Related]
11. ARID1A gene mutation in ovarian and endometrial cancers (Review).
Takeda T; Banno K; Okawa R; Yanokura M; Iijima M; Irie-Kunitomi H; Nakamura K; Iida M; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
Oncol Rep; 2016 Feb; 35(2):607-13. PubMed ID: 26572704
[TBL] [Abstract] [Full Text] [Related]
12. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
Kim YS; Choi KC; Hwang KA
Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
[TBL] [Abstract] [Full Text] [Related]
13. Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via smad2/3 signaling.
Qiu X; Cheng JC; Zhao J; Chang HM; Leung PC
Cell Signal; 2015 Oct; 27(10):1956-62. PubMed ID: 26186970
[TBL] [Abstract] [Full Text] [Related]
14. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
[TBL] [Abstract] [Full Text] [Related]
15. The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.
Peng J; Yoshioka Y; Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Kharma B; Murakami R; Abiko K; Murphy SK; Konishi I
Mol Carcinog; 2016 Apr; 55(4):335-45. PubMed ID: 25663289
[TBL] [Abstract] [Full Text] [Related]
16. Adult granulosa cell tumours of the ovary.
Mancari R; Portuesi R; Colombo N
Curr Opin Oncol; 2014 Sep; 26(5):536-41. PubMed ID: 25024052
[TBL] [Abstract] [Full Text] [Related]
17. Effects of 4-nonylphenol and bisphenol A on stimulation of cell growth via disruption of the transforming growth factor-β signaling pathway in ovarian cancer models.
Park MA; Choi KC
Chem Res Toxicol; 2014 Jan; 27(1):119-28. PubMed ID: 24308608
[TBL] [Abstract] [Full Text] [Related]
18. Expression profiling of nuclear receptors identifies key roles of NR4A subfamily in uterine fibroids.
Yin H; Lo JH; Kim JY; Marsh EE; Kim JJ; Ghosh AK; Bulun S; Chakravarti D
Mol Endocrinol; 2013 May; 27(5):726-40. PubMed ID: 23550059
[TBL] [Abstract] [Full Text] [Related]
19. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells.
Cheng JC; Auersperg N; Leung PC
PLoS One; 2012; 7(8):e42436. PubMed ID: 22905131
[TBL] [Abstract] [Full Text] [Related]
20. Engulfment protein GULP is regulator of transforming growth factor-β response in ovarian cells.
Ma CI; Martin C; Ma Z; Hafiane A; Dai M; Lebrun JJ; Kiss RS
J Biol Chem; 2012 Jun; 287(24):20636-51. PubMed ID: 22451657
[TBL] [Abstract] [Full Text] [Related]
[Next]
